Total Visits

Views
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. 55

Total Visits Per Month

January 2019February 2019March 2019April 2019May 2019June 2019July 2019
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. 5 2 0 2 8 8 2

File Visits

Views
12885_2018_Article_4442.pdf 32

Top country views

Views
United States 24
Egypt 6
United Kingdom 3
Germany 2
Pakistan 2
Canada 1
Russia 1

Top cities views

Views
Ashburn 6
Cambridge 4
Woodbridge 4
Fairfield 3
Islamabad 2
Mountain View 2
Ann Arbor 1
Houston 1
Wilmington 1